Moody's Investors Service affirmed its "Baa2" revenue bond rating for Chattanooga, Tenn.-based Erlanger Health System, affecting $50 million of rated bonds.
The rating reflects Moody's expectation that Erlanger will translate market share growth and strong top-line revenue into improved financial performance.
The rating outlook has been revised from positive to stable.